Skip to main content
Signal8

Kura Oncology, Inc. (KURA)

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Kura Oncology, Inc. logo

Kura Oncology, Inc.

NASDAQ:KURAHealthcare
-2.84%$10.26
AH$10.31+0.49%vs close
Mkt Cap$912.74M
Float78.14M
O/S88.96M
Vol
$ Vol
RVOL
Inst Own97.7%
SI18.3%
Earnings
Dilution
Financials Summary
Revenue$67.48M
Net Income-$278.67M
Total Assets$738.36M
Free Cash Flow-$70.7M
Debt & Equity
Debt 11%
Equity 89%
Total Debt$20.46M
Total Equity$174.13M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in KURA's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$738.36M
Liabilities$564.23M
Accounts Receivable$12.6M
Accounts Payable$5.02M
Inventory$413K
PP&E (Net)$15.16M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue$67.48M$53.88M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth25.2%-----------------
Cost of Revenue$57K$0$849K$0$0$194K$0$10K$30K$31K$20K$24K$23K$22K$23K$21K$19K$0
Gross Profit$67.42M$53.88M-$849K$0$0-$194K$0-$10K-$30K-$31K-$20K-$24K-$23K-$22K-$23K-$21K-$19K$0
Gross Margin99.9%100.0%----------------
Research and Development$251.07M$169.97M$115.23M$92.81M$84.72M$60.4M$47.83M$46.79M$26.43M$20.4M$17.78M$8.05M$0$0$0$0$0$0
Selling, General, and Administrative$119.98M$77.11M$50.57M$47.05M$46.54M$31.31M$19.65M$16.1M$9.65M$7.96M$6.09M$3.85M$22K$23K$21K$21K$19K$0
Other$0$0-$849K$0$0$0$0$0$0$0$0$2M$0$0$0$0$0-$34K
Total Operating Expenses$371.06M$247.08M$164.96M$139.87M$131.26M$91.7M$67.48M$62.88M$36.08M$28.37M$23.86M$10.9M$22K$23K$21K$21K$19K-$34K
Operating Income (EBIT)-$303.63M-$193.19M-$165.8M-$139.87M-$131.26M-$91.9M-$67.48M-$62.88M-$36.08M-$28.37M-$23.86M-$11.8M-$22K-$23K-$21K-$41K-$38K-$34K
Operating Margin-449.9%-358.5%----------------
Interest Expense$1.51M$1.62M$1.55M$229K$414K$578K$580K$970K$888K$577K$88K$6K$5K$4K$2K$2K$838$0
Interest Income$26.77M$22.85M$14.72M$4.25M$1.21M$2.8M$4.67M$3.17M$751K$499K$128K$0$0$0$0$0$0$0
Other Income (Expense)$25.26M$21.23M$13.17M$4.03M$792K$2.27M$4.44M$2.64M$943K$807K$972K$879K$17K$17K$20K$19K$18K$0
Income Before Tax (EBT)-$278.37M-$171.97M-$152.63M-$135.84M-$130.47M-$89.63M-$63.14M-$60.45M-$35.43M-$27.56M-$22.63M-$11.01M-$27K-$27K-$22K-$22K-$20K-$34K
Income Tax Expense$297K$2.02M$0$0$0$0$0$0-$30K-$31K-$20K$0$0$0$0$0$0$0
Net Income-$278.67M-$173.98M-$152.63M-$135.84M-$130.47M-$89.63M-$63.14M-$60.45M-$35.43M-$27.56M-$22.63M-$11.01M-$27K-$27K-$22K-$22K-$20K-$34K
Net Income Margin-412.9%-322.9%----------------
Supplementary Data
EPS-3.18-2.02-2.08-2.03-1.97-1.69-1.51-1.72-1.52-1.47-2.28-2.69-0.01-0.01-0.00-0.00-0.00-0.01
Diluted EPS-3.18-2.02-2.08-2.03-1.97-1.69-1.51-1.72-1.52-1.47-2.28-2.69-0.01-0.01-0.00-0.00-0.00-0.01
Weighted Average OS87.68M86.16M73.23M66.99M66.35M53.08M41.95M35.19M23.24M18.70M9.93M4.09M5.00M5.00M5.00M5.00M5.00M5.00M
EBITDA-$275.82M-$169.5M-$150.23M-$134.85M-$129.49M-$88.85M-$67.47M-$62.87M-$36.05M-$28.34M-$23.84M-$11.8M-$22K-$23K-$21K-$41K-$38K-$34K
EBITDA Margin-408.7%-314.6%----------------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Assets
Current Assets
Cash and Cash Equivalents$149.1M$224.46M$37.32M$51.8M$90.67M$325.49M$26.14M$16.12M$11.43M$9.72M$15.44M$1.12M$7K$5K$4K$27K$11K$8K
Short-Term Investments$518.14M$502.93M$386.64M$386.18M$427.29M$307.83M$210.76M$162.87M$81.71M$58.06M$70.3M$0$0$0$0$0$0$0
Cash and Short-Term Investments$667.24M$727.39M$423.96M$437.99M$517.96M$633.32M$236.89M$178.99M$93.14M$67.79M$85.75M$1.12M$7K$5K$4K$27K$11K$8K
Accounts Receivable$12.6M$0$0$0$0$0$30K$224K$216K$295K$430K$30K$0$0$0$0$0$0
Inventory$413K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$28.41M$17.43M$8.52M$8.44M$1.4M$0-$30K$1.99M$1.28M$725K$0$0$0$4K$3K$0$0$0
Total Current Assets$708.66M$744.83M$432.48M$446.43M$522.29M$637.29M$239.6M$181.2M$94.64M$68.81M$86.87M$1.2M$7K$8K$7K$27K$11K$8K
Long-Term Assets
Property, Plant & Equipment Net$15.16M$7.49M$8.85M$6.38M$8.25M$8.36M$278K$0$10K$40K$71K$27K$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$14.54M$7.84M$7.6M$3.5M$3.52M$1.56M$2.09M$1.18M$1.2M$971K$319K$155K$3K$0$0$0$0$0
Total Long-Term Assets$29.7M$15.33M$16.45M$9.88M$11.76M$9.92M$2.37M$1.18M$1.21M$1.01M$390K$182K$3K$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$3K$2K$0
Total Assets$738.36M$760.16M$448.94M$456.31M$534.05M$647.21M$241.97M$182.38M$95.85M$69.82M$87.26M$1.38M$9K$8K$7K$29K$13K$8K
Liabilities
Current Liabilities
Accounts Payable$5.02M$1.47M$2.3M$1.53M$3.24M$2.75M$3.53M$3.94M$1.25M$638K$928K$226K$350$2K$3K$0$0$0
Short-Term Debt$0$2.61M$0$0$0$3M$250K$0$1.53M$0$0$2.04M$110K$85K$60K$60K$25K$0
Current Income Tax Payable$0$2.06M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$48.98M$24.27M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$22.37M$17.51M$13.15M$10.3M$7.92M$7.02M$3.69M-$185K$0$0$0$0$0$0$0$0$0$0
Total Current Liabilities$116.97M$78.71M$35.26M$24.06M$22.45M$26.02M$15.56M$13.62M$10.03M$5.45M$5.05M$3.02M$110K$104K$75K$60K$25K$0
Long-Term Liabilities
Long-Term Debt$9.71M$6.92M$9.33M$9.16M$0$4.25M$7.25M$7.5M$5.57M$7.32M$0$493K$110K$85K$60K$0$0$0
Long-Term Unearned Revenue$424.91M$253.91M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$3.16M$1.79M$705K$265K$375K$395K$377K$279K$388K$170K$101K$1.3M-$87K-$68K-$48K$10K$7K$0
Total Long-Term Liabilities$447.25M$267.81M$16.4M$11.97M$4.99M$10.28M$7.63M$7.78M$5.96M$7.49M$101K$1.79M$110K$85K$60K$10K$7K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0-$87K-$85K-$60K$0$0$0
Total Liabilities$564.23M$346.52M$51.66M$36.03M$27.44M$36.31M$23.19M$21.39M$15.99M$12.95M$5.16M$4.81M$133K$104K$75K$70K$32K$0
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$9K$8K$7K$7K$7K$7K$5K$4K$3K$2K$2K$50K$500$500$500$500$500$500
Retained Earnings-$1.17B-$895.42M-$721.44M-$568.81M-$432.97M-$302.5M-$212.88M-$149.74M-$89.29M-$53.86M-$26.3M-$3.67M-$174K-$145K-$118K-$91K-$69K-$49K
Comprehensive Income & Other$1.02M$764K-$1.27M-$8.03M-$1.79M$46K$331K-$131K-$49K-$18K-$87K-$1K$0$0$0$0$0$0
Other Stockholders' Equity$1.35B$1.31B$1.12B$989.08M$939.57M$913.4M$431.65M$310.72M$169.15M$110.73M$108.4M$188K$50K$50K$50K$50K$50K$50K
Total Equity$174.13M$413.64M$397.27M$420.28M$506.61M$610.9M$218.78M$160.99M$79.86M$56.88M$82.1M-$3.43M-$124K-$95K-$68K-$41K-$19K$1K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$738.36M$760.16M$448.94M$456.31M$534.05M$647.21M$241.97M$182.38M$95.85M$69.82M$87.26M$1.38M$9K$8K$7K$29K$13K$1K
Supplementary Data
Total Debt$20.46M$16.59M$17.2M$14.02M$6.88M$14.98M$7.75M$7.5M$7.1M$7.32M$0$2.53M$220K$170K$120K$60K$25K$0
Net Debt-$128.64M-$207.87M-$20.12M-$37.78M-$83.8M-$310.52M-$18.38M-$8.62M-$4.33M-$2.4M-$15.44M$1.41M$213K$165K$116K$33K$14K-$8K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Operating Activities
Net Income-$278.67M-$173.98M-$152.63M-$135.84M-$130.47M-$89.63M-$63.14M-$60.45M-$35.43M-$27.56M-$22.63M-$11K-$27K-$27K-$22K-$22K$0$0
Depreciation & Amortization$1.03M$848K$849K$759K$558K$194K$10K$10K$30K$31K$20K$1K$0$0$0$0$0$0
Deferred Income Tax$0$0$0$0$4.6M$0$0-$1.44M-$260K$129K$439K$0$0$0$0$0$0$0
Stock-Based Compensation$37.11M$33.9M$28.08M$26.32M$23.58M$12.81M$9.41M$8.65M$4.54M$2.09M$2.26M$711$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable-$6.74M$0$0$0$0$0$210K-$8K$79K$135K-$400K-$90$0$0$0$0$0$0
  Inventory-$413K$0$0$0$0$0-$856K-$443K-$750K-$199K$153K$0$0$0$0$0$0$0
  Accounts Payable$4.5M$15.2M$10.33M-$802K-$2.52M$5.68M$856K$5.1M$3.61M$471K$2.81M-$2K-$1K$762$2K$4K$0$0
  Other Working Capital$187.1M$270.97M-$2.51M-$2.18M-$706K$707K-$136K-$270K-$375K-$487K-$1.16M$3K-$7K-$28K-$2K-$4K$0$0
Total Working Capital Change$184.44M$286.17M$7.82M-$2.98M-$3.22M$6.38M$74K$4.38M$2.56M-$80K$1.4M$3K-$8K-$27K-$66K$4K$0$0
Other Non-Cash Items-$7.97M-$12.62M-$8.94M$1.68M$399K$410K-$1.11M$184K$118K$42K$579K$3K$11K$32K$69K-$625$0$0
Net Cash from Operating-$64.06M$134.32M-$124.82M-$110.06M-$104.55M-$69.83M-$54.76M-$48.66M-$28.44M-$25.35M-$17.93M-$3K-$24K-$23K-$19K-$19K-$21K-$32K
Investing Activities
Capital Expenditures-$6.64M-$472K-$168K-$626K-$1.15M-$2.17M$0$0$0$0-$64K-$84$0$0$0$0$0$0
Acquisitions$0$0$0-$33K$126K$98K$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$761.59M-$659.05M-$409.82M-$270.65M-$445.66M-$320.96M-$227.57M-$237.44M-$100.64M-$56.43M-$76.56M$0$0$0$0$0$0$0
Sales of Investments$755.13M$557.93M$425.55M$303.91M$319.97M$223.2M$181.25M$158.14M$77.22M$68.61M$6M$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$33K-$126K-$98K$0-$79K-$23K$12K-$71K-$28K$0$0$0$0$0$0
Net Cash from Investing-$13.1M-$101.59M$15.56M$32.63M-$126.83M-$99.94M-$46.33M-$79.3M-$23.42M$12.18M-$70.63M-$84$0$0$0$0$0$0
Financing Activities
Debt Repaid----$10M$7.25M$250K-$623K$344K-$7.45M-$5M-------
Common Stock Issuance$1.79M$145.81M$93.58M$24.72M$4.43M$459.33M$108.17M$132.17M$53.68M$0$97.87M$0$0$0$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$1K-$7K-$5K-$4K$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$8.6M$1.21M$3.84M-$611K$10.25M$2.94M$1.09M$53.57M$0$0$2M$25K$25K$35K$35K$25K$0
Net Cash from Financing$1.79M$154.42M$94.78M$38.56M-$3.44M$469.33M$111.1M$132.64M$53.57M$7.45M$102.87M$6K$25K$25K$35K$35K$25K$0
Forex Effect$0$0$0$0$0$0$0$0$0$0$0-$7K$0$0$0$0$0$0
Net Change in Cash-$75.36M$187.14M-$14.48M-$38.87M-$234.82M$299.57M$10.02M$4.69M$1.71M-$5.72M$14.32M$1.12M$582-$23K$16K$16K$4K-$32K
Supplementary Data
Operating Cash Flow-$64.06M$134.32M-$124.82M-$110.06M-$104.55M-$69.83M-$54.76M-$48.66M-$28.44M-$25.35M-$17.93M-$3K-$24K-$23K-$19K-$19K-$21K-$32K
Capital Expenditure-$6.64M-$472K-$168K-$626K-$1.15M-$2.17M$0$0$0$0-$64K-$84$0$0$0$0$0$0
Free Cash Flow-$70.7M$133.84M-$124.99M-$110.69M-$105.7M-$72M-$54.76M-$48.66M-$28.44M-$25.35M-$17.99M-$3K-$24K-$23K-$19K-$19K-$21K-$32K
Cash at Beginning$224.46M$37.32M$51.8M$90.88M$325.7M$26.14M$16.12M$11.43M$9.72M$15.44M$1.12M$7K$6K$27K-$12K$11K$0$0
Cash at End$149.1M$224.46M$37.32M$52.01M$90.88M$325.7M$26.14M$16.12M$11.43M$9.72M$15.44M$1.12M$7K$5K$4K$27K$4K-$32K